CD56+, NKp46+ cell line (MZ93) expressing T-cell and myeloid antigens

Leukemia Research

Volumn 26, Issue 3, 2002, Pages 289-295

  Hashimoto, Shigeo ^a   Toba, Ken ^a   Tsuchiyama, Junjiro ^a   Abe, Takashi ^a   Yano, Toshio ^a   Momoi, Akihito ^a   Okazuka, Kiyoshi ^a   Kanazawa, Naoko ^a   Takahashi, Masuhiro ^b   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

CD56; Cell line; Chronic myelogeneous leukemia; MZ93; NKp46; T NK cell precursor acute leukemia

Indexed keywords

BUSULFAN; CD3 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CYTARABINE; DAUNORUBICIN; HYDROXYUREA; INTERLEUKIN 2 RECEPTOR; MICROSOMAL AMINOPEPTIDASE; PREDNISOLONE; RANIMUSTINE; VINCRISTINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL CRISIS; CASE REPORT; CELL CULTURE; CELL ISOLATION; CELL LINE; CHROMOSOME 6P; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FATALITY; FEVER; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; KARYOTYPE; LUNG HEMORRHAGE; MALE; NATURAL KILLER CELL; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD56; BIOLOGICAL MARKERS; CYTOPLASM; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0036138888     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00115-1     Document Type: Article

References (40)

1. Establishment of an IL-2-dependent cell line derived from 'nasal type' NK/T-cell lymphoma of CD2+, sCD3-, CD3ε+, CD56+ phenotype and associated with the Epstein-Barr virus
2. A novel natural killer cell line from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation
3. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells
4. Characterization of a cell line, NKL, derived from an aggressive human natural killer leukemia
5. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection
6. TCGF (IL-2)-receptor inducing factor(s). I. Regulation of IL-2 receptor on a natural killer-like cell line (YT cells)
7. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma
8. Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes
9. Comparative studies of CD3- and CD3+CD56+ cells: examination of morphology, function, T cell receptor rearrangement, and pore-forming protein expression
10. Increase in proportion of granulated CD56+ T cells in patients with malignancy
11. Report of the Committee on the Genetic Constitution of Chromosomes 10, 11, and 12
12. Different genetic pathways in leukemogenesis for patients presenting with therapy-related acute myeloid leukemia
13. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders
14. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
15. Characterization and sensitivity to interleukin 2 and interferon alpha of leukemic cells from a patient with large granular lymphocytic leukemia associated with chronic active Epstein-Barr virus infection
16. Malignancies of natural killer (NK) precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia
17. Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia
18. Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome
19. Neural cell adhesion molecule (CD56)-positive acute melogenous leukemia and myelodysplastic and myeloproliferative syndromes
20. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19)
21. The immunophenotype of adult acute myeloid leukemia. High frequency of lymphoid antigen expression and comparison of immunophentype, French-American-British classification, and karyotypic abnormalities
22. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity
23. Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor
24. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes
25. Hematopoietic cytokine-dependent differentiation to eosinophils and neutrophils in a newly established acute promyelocytic leukemia cell line with t(15;17)
26. Novel technique for the direct flow cytofluorometric analysis of human basophils in unseparated blood and bone marrow, and the characterization of phenotype and peroxidase of human basophils
27. p46, a novel natural killer cell-specific surface molecule that mediated cell activation
28. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
29. FLT-3 ligand and marrow stroma-derived factors promote CD3γ, CD3δ, CD3ζ, and RAG-2 gene expression in primary human CD34+LIN-DR- marrow progenitors
30. Expression of CD3ε, CD3ζ, and RAG-1/RAG-2 in decidual CD56+NK cells
31. Megakaryoblastic leukemia: the characterization and identification of megakaryoblasts
32. Biology and clinical relevance of human natural killer cells
33. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells
34. Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells
35. Acute undifferentiated leukemia with an unusual CD7+CD56+CD33+ immunophenotype of NK progenitors [letter]
36. HLA-DR-, CD33+, CD56+, CD16-, myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3
37. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3ε,δ proteins
38. CD3γ, CD3δ, CD3ζ mRNA in adult human marrow hematopoietic progenitors correlates with surface CD2 and CD7 expression
39. Guidelines for the characterization and publication of human malignant hematopoietic cell lines
40. False human hematopoietic cell lines: cross-contaminations and misinterpretations